With the FTC’s more expansive approach to antitrust, PBMs are in the crosshairs

WASHINGTON — The Democrats leading the Federal Trade Commission are hoping to expand the agency’s authority to crack down on unfair business practices — and the shift could have major implications for its ongoing scrutiny of pharmacy benefit managers.

Read the full story >